• New Data Shed Light On T-Cell Response To COVID-19, Other News

    Clinical Research News | New data shed light on the potential variations in T-cell responses as a function of disease severity, an issue that is key to understanding the potential role of immunopathology in COVID-19, and also inform vaccine design and evaluation. Meanwhile, universities are continuing to build out their telehealth capabilities in light of the pandemic. This, plus more, are included in this week’s announcements and updates from the clinical research industry.

    Jul 2, 2020

  • Could Plasma Dilution Be The Answer To Age-Related Diseases—and Cytokine Storm?

    Clinical Research News | Therapeutic plasma exchange, a 30-year-old clinical procedure, could explode in popularity if its mouse equivalent holds true in humans—reduction in damaging proteins that have been implicated in diseases such as Alzheimer’s disease and heart failure.

    Jun 29, 2020

  • Socioeconomic Status May Determine COVID-19’s Impact, Other News and Updates

    Clinical Research News | New research indicates that COVID-19 disproportionately affects those of lower socioeconomic status and greater household crowding. Meanwhile, companies are forming a crowd-sourcing initiative to jump start COVID-19 data collection. This, plus more, are included in this week’s announcements and updates from the clinical research industry.

    Jun 26, 2020

  • Dynatrace, Seven Bridges, Trialbee, And More: News From June 2020

    Clinical Research News | June was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Dynatrace, Seven Bridges, Trialbee, and more.

    Jun 25, 2020